Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahdi Barzegar

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Iranian Journal of Neurology|September 14, 2018
Serum leptin levels in Iranian patients with Parkinson's diseaseMehri Salari, Mahdi Barzegar, Masoud Etemadifar, et al.
Clinical Case Reports|March 1, 2022
Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccinationOmid Mirmosayyeb, Mahdi Barzegar, Mina Rezaei, et al.
Polish Journal of Radiology|August 18, 2022
Diagnostic accuracy and prognostic value of lung ultrasound in coronavirus disease (COVID-19)Javid Azadbakht, Maryam Saffari, Hamidreza Talarie, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 8, 2021
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysisAbdorreza Naser Moghadasi, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Current Journal of Neurology|November 27, 2023
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Neurology Research International|August 2, 2021
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple SclerosisNasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders|December 15, 2020
Frequency of comorbidities in Neuromyelitis Optica spectrum disorderMahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Multiple Sclerosis and Related Disorders|May 12, 2021
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective studyMahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders|July 3, 2021
Early predictors of conversion to secondary progressive multiple sclerosisMahdi Barzegar, Soroush Najdaghi, Alireza Afshari-Safavi, et al.
Plos One|April 19, 2022
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysisOmid Mirmosayyeb, Narges Ebrahimi, Mahdi Barzegar, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Iranian Journal of Neurology|September 14, 2018
Serum leptin levels in Iranian patients with Parkinson's diseaseMehri Salari, Mahdi Barzegar, Masoud Etemadifar, et al.
Clinical Case Reports|March 1, 2022
Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccinationOmid Mirmosayyeb, Mahdi Barzegar, Mina Rezaei, et al.
Polish Journal of Radiology|August 18, 2022
Diagnostic accuracy and prognostic value of lung ultrasound in coronavirus disease (COVID-19)Javid Azadbakht, Maryam Saffari, Hamidreza Talarie, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 8, 2021
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysisAbdorreza Naser Moghadasi, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Current Journal of Neurology|November 27, 2023
Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, et al.
Neurology Research International|August 2, 2021
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple SclerosisNasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders|December 15, 2020
Frequency of comorbidities in Neuromyelitis Optica spectrum disorderMahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Multiple Sclerosis and Related Disorders|May 12, 2021
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective studyMahdi Barzegar, Saeed Vaheb, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders|July 3, 2021
Early predictors of conversion to secondary progressive multiple sclerosisMahdi Barzegar, Soroush Najdaghi, Alireza Afshari-Safavi, et al.
Plos One|April 19, 2022
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysisOmid Mirmosayyeb, Narges Ebrahimi, Mahdi Barzegar, et al.
Pageof 5